UniSuper Management Pty »

Design Therapeutics shares owned by UniSuper Management Pty

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by UniSuper Management Pty from 13F filings

Historical chart of UniSuper Management Pty investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by UniSuper Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by UniSuper Management Pty

Quarter filed Position value Share count Share price at filing
2023-06-30 $648k 103k 6.30

More positions owned by UniSuper Management Pty

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Bank of America Corporation (BAC)
Netflix (NFLX)
Oracle Corporation (ORCL)
salesforce (CRM)

View all positions for UniSuper Management Pty

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Almitas Capital
Vanguard Group
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics